Challenges in COVID-19 Vaccine Distribution: Temperature Control and Tracking

Strategic Insights -

The COVID-19 pandemic has highlighted the complexities of vaccine distribution, particularly the challenge of maintaining ultra-cold temperatures required for mRNA vaccines developed by Pfizer/BioNTech and Moderna. These vaccines must be stored at temperatures below -112 F (-80 C) and -4 F (-20 C) respectively, which is a significant logistical challenge. To address this issue, companies are using dry ice, thermal shippers, and freezers to maintain the required temperatures. However, the high demand for freezers and dry ice has created a risk of shortage, emphasizing the need for efficient supply chain management.

Key Takeaways:

  • The Pfizer vaccine requires storage at temperatures between -112 F (-80 C) and -94 F (-70 C), while the Moderna vaccine requires temperatures around -4 F (-20 C).
  • Moderna's vaccine can remain at -4 F for up to six months and then for a month in a refrigerator, whereas Pfizer's vaccine has a shorter shelf life of five days after being transferred from ultracold storage to a refrigerator.
  • Pfizer and Moderna are using different distribution strategies, with Pfizer manufacturing its vaccines in Kalamazoo, Michigan, and shipping them to administration sites after transportation in thermal shippers.
  • The Federal Aviation Administration has granted permission to transport up to five times the normally permitted amount of dry ice along with the vaccines.
  • Staff at administration sites must be trained to monitor temperatures and maintain the integrity of the vaccines.
  • The Centers for Disease Control and Prevention is issuing guidelines to ensure efficient vaccine distribution, while insurance companies and the government are considering coverage for the vaccines.

Statistics:

  • $34 billion worth of vaccines were wasted in 2019 due to fluctuations in temperature during transportation.
  • Pfizer's thermal shippers require about 50 pounds of dry ice to maintain the required temperature for a few days.
  • Vulnerable populations, such as those with compromised immune systems, are at the forefront of vaccine distribution efforts.

Sources:

  • The Conversation (under a Creative Commons license)
  • HT Media Ltd. (SyndiGate Media Inc.)
  • Federal Aviation Administration (FAA)
  • Centers for Disease Control and Prevention (CDC)